Cargando…

Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis

BACKGROUND: Preeclampsia is a complication during pregnancy characterised by new-onset hypertension and proteinuria that develops after 20 weeks of gestation. Dyslipidemia in pregnancy is correlated with an increased risk of preeclampsia. However, the dynamic changes in lipid metabolic product, part...

Descripción completa

Detalles Bibliográficos
Autores principales: Herlambang, Herlambang, Puspasari, Anggelia, Maharani, Citra, Enis, Rina Nofri, Tarawifa, Susan, Fitri, Amelia Dwi, Harahap, Huntari, Harahap, Asro Hayani, Kusdiyah, Erny, Syamsunarno, Mas Rizky Anggun Adipurna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722156/
https://www.ncbi.nlm.nih.gov/pubmed/34980007
http://dx.doi.org/10.1186/s12884-021-04313-3
_version_ 1784625473761837056
author Herlambang, Herlambang
Puspasari, Anggelia
Maharani, Citra
Enis, Rina Nofri
Tarawifa, Susan
Fitri, Amelia Dwi
Harahap, Huntari
Harahap, Asro Hayani
Kusdiyah, Erny
Syamsunarno, Mas Rizky Anggun Adipurna
author_facet Herlambang, Herlambang
Puspasari, Anggelia
Maharani, Citra
Enis, Rina Nofri
Tarawifa, Susan
Fitri, Amelia Dwi
Harahap, Huntari
Harahap, Asro Hayani
Kusdiyah, Erny
Syamsunarno, Mas Rizky Anggun Adipurna
author_sort Herlambang, Herlambang
collection PubMed
description BACKGROUND: Preeclampsia is a complication during pregnancy characterised by new-onset hypertension and proteinuria that develops after 20 weeks of gestation. Dyslipidemia in pregnancy is correlated with an increased risk of preeclampsia. However, the dynamic changes in lipid metabolic product, particularly fatty acid fraction, in preeclampsia maternal circulation, are not well understood. This study aimed to investigate fatty acid fraction in preeclampsia maternal blood compared with normotensive normal pregnancy. METHODS: A total of 34 women who developed preeclampsia and 32 women with normotensive normal pregnancy were included in our case-control study. Maternal blood samples were collected for serum fatty acid fractions analysis and other biochemical parameters. Serum fatty acid fractions included long-chain polyunsaturated fatty acid (LCPUFA), monounsaturated fatty acid (MUFA), saturated fatty acid, and total fatty acid, measured with gas chromatography-mass spectrometry (GC-MS). The mean difference of fatty acid level was analysed using parametric and non-parametric bivariate analysis based on normality distributed data, while the risk of preeclampsia based on fatty acid fraction was analysed using a logistic regression model. RESULTS: Women with preeclampsia have lower high-density lipoprotein (53.97 ± 12.82 mg/dL vs. 63.71 ± 15.20 mg/dL, p = 0.006), higher triglyceride (284.91 ± 97.68 mg/dL vs. 232.84 ± 73.69 mg/dL, p = 0.018) than that in the normotensive group. Higher palmitoleic acid was found in women with preeclampsia compared to normotensive normal pregnancy (422.94 ± 195.99 vs. 325.71 ± 111.03 μmol/L, p = 0.037). The binary logistic regression model showed that pregnant women who had total omega-3 levels within the reference values had a higher risk of suffering preeclampsia than those with the higher reference value (odds ratio OR (95% CI): 8,5 (1.51–48.07), p = 0.015). Pregnant women who have saturated fatty acid within reference values had a lower risk for suffering preeclampsia than those in upper reference value (OR (95% CI): 0.21 (0.52–0.88), p = 0.032). CONCLUSION: Overall, palmitoleic acid was higher in women with preeclampsia. Further analysis indicated that reference omega-3 in and high saturated fatty acid serum levels are characteristics of women with preeclampsia.
format Online
Article
Text
id pubmed-8722156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87221562022-01-06 Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis Herlambang, Herlambang Puspasari, Anggelia Maharani, Citra Enis, Rina Nofri Tarawifa, Susan Fitri, Amelia Dwi Harahap, Huntari Harahap, Asro Hayani Kusdiyah, Erny Syamsunarno, Mas Rizky Anggun Adipurna BMC Pregnancy Childbirth Research BACKGROUND: Preeclampsia is a complication during pregnancy characterised by new-onset hypertension and proteinuria that develops after 20 weeks of gestation. Dyslipidemia in pregnancy is correlated with an increased risk of preeclampsia. However, the dynamic changes in lipid metabolic product, particularly fatty acid fraction, in preeclampsia maternal circulation, are not well understood. This study aimed to investigate fatty acid fraction in preeclampsia maternal blood compared with normotensive normal pregnancy. METHODS: A total of 34 women who developed preeclampsia and 32 women with normotensive normal pregnancy were included in our case-control study. Maternal blood samples were collected for serum fatty acid fractions analysis and other biochemical parameters. Serum fatty acid fractions included long-chain polyunsaturated fatty acid (LCPUFA), monounsaturated fatty acid (MUFA), saturated fatty acid, and total fatty acid, measured with gas chromatography-mass spectrometry (GC-MS). The mean difference of fatty acid level was analysed using parametric and non-parametric bivariate analysis based on normality distributed data, while the risk of preeclampsia based on fatty acid fraction was analysed using a logistic regression model. RESULTS: Women with preeclampsia have lower high-density lipoprotein (53.97 ± 12.82 mg/dL vs. 63.71 ± 15.20 mg/dL, p = 0.006), higher triglyceride (284.91 ± 97.68 mg/dL vs. 232.84 ± 73.69 mg/dL, p = 0.018) than that in the normotensive group. Higher palmitoleic acid was found in women with preeclampsia compared to normotensive normal pregnancy (422.94 ± 195.99 vs. 325.71 ± 111.03 μmol/L, p = 0.037). The binary logistic regression model showed that pregnant women who had total omega-3 levels within the reference values had a higher risk of suffering preeclampsia than those with the higher reference value (odds ratio OR (95% CI): 8,5 (1.51–48.07), p = 0.015). Pregnant women who have saturated fatty acid within reference values had a lower risk for suffering preeclampsia than those in upper reference value (OR (95% CI): 0.21 (0.52–0.88), p = 0.032). CONCLUSION: Overall, palmitoleic acid was higher in women with preeclampsia. Further analysis indicated that reference omega-3 in and high saturated fatty acid serum levels are characteristics of women with preeclampsia. BioMed Central 2022-01-03 /pmc/articles/PMC8722156/ /pubmed/34980007 http://dx.doi.org/10.1186/s12884-021-04313-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Herlambang, Herlambang
Puspasari, Anggelia
Maharani, Citra
Enis, Rina Nofri
Tarawifa, Susan
Fitri, Amelia Dwi
Harahap, Huntari
Harahap, Asro Hayani
Kusdiyah, Erny
Syamsunarno, Mas Rizky Anggun Adipurna
Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis
title Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis
title_full Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis
title_fullStr Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis
title_full_unstemmed Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis
title_short Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis
title_sort comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722156/
https://www.ncbi.nlm.nih.gov/pubmed/34980007
http://dx.doi.org/10.1186/s12884-021-04313-3
work_keys_str_mv AT herlambangherlambang comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT puspasarianggelia comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT maharanicitra comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT enisrinanofri comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT tarawifasusan comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT fitriameliadwi comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT harahaphuntari comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT harahapasrohayani comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT kusdiyaherny comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis
AT syamsunarnomasrizkyanggunadipurna comprehensivefattyacidfractionationprofillinginpreeclampsiaacasecontrolstudywithmultivariableanalysis